Study identifier:NIS-CKR-DUM-2009/2
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A multi-center, prospective, observational study to assess the effect of patient education related to CV Risk factors in type 2 diabetes mellitus
Glycemia
-
No
-
All
4045
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
1 Type II DM and Hypertension and/or Hyperlipidemia | - |